Intrua Financial, LLC Gilead Sciences, Inc. Transaction History

Intrua Financial, LLC

$502 Million
Q1 2023

A detailed history of Intrua Financial, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Intrua Financial, LLC holds 10,650 shares of GILD stock, worth $902,481. This represents 0.18% of its overall portfolio holdings.

Number of Shares

10,650

Previous 10,146 4.97%

Holding current value

$902,481

Previous $871,000 1.38%

% of portfolio

0.18%

Previous 0.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $38,964 - $44,392	504 Added 4.97%	10,650 $883,000
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $533,521 - $765,952	-8,561 Reduced 45.76%	10,146 $0
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $399,215 - $456,007	-6,705 Reduced 26.39%	18,707 $1.15 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $51,082 - $57,533	885 Added 3.61%	25,412 $1.57 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $111,090 - $139,208	-1,918 Reduced 7.25%	24,527 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $57,678 - $65,465	889 Added 3.48%	26,445 $1.92 Million
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $480,531 - $518,439	7,099 Added 38.46%	25,556 $1.71 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $17,454 - $19,071	-275 Reduced 1.47%	18,457 $1.29 Million
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $23,340 - $26,630	389 Added 2.12%	18,732 $1.21 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $14,219 - $16,202	-251 Reduced 1.35%	18,343 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $530,706 - $667,271	8,546 Added 85.05%	18,594 $1.13 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $726,872 - $844,032	10,048 New	10,048 $685,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.

Account

Intrua Financial, LLC Gilead Sciences, Inc. Transaction History